TLR4 and neoplasm: In particular, TLR4 promotes tumor cell proliferation, invasion, survival and migration, the induction of epithelial–mesenchymal transition (EMT), the expansion of cancer stem-cells (CSCs), resistance to paclitaxel [12], and immune suppression in the TME [13].